Welcome to LookChem.com Sign In|Join Free
  • or
4-{[(trifluoromethyl)sulfonyl]amino}benzoic acid is a chemical compound with the molecular formula C8H5F3NO4S. It is a derivative of benzoic acid, featuring a trifluoromethylsulfonyl group attached to the amino group, which is in turn connected to the 4-position of the benzene ring. 4-{[(trifluoromethyl)sulfonyl]amino}benzoic acid is known for its potential applications in the synthesis of various pharmaceuticals and agrochemicals due to its unique reactivity and stability. It is often used as an intermediate in the preparation of compounds with specific biological activities, such as anti-inflammatory or analgesic properties. The trifluoromethylsulfonyl group imparts increased lipophilicity and metabolic stability to the molecules in which it is incorporated, making it a valuable moiety in drug design.

5433-54-5

Post Buying Request

5433-54-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5433-54-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 5433-54-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,4,3 and 3 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 5433-54:
(6*5)+(5*4)+(4*3)+(3*3)+(2*5)+(1*4)=85
85 % 10 = 5
So 5433-54-5 is a valid CAS Registry Number.

5433-54-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(trifluoromethylsulfonylamino)benzoic acid

1.2 Other means of identification

Product number -
Other names N-(4-carboxyphenyl)trifluoromethanesulfonamide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:5433-54-5 SDS

5433-54-5Relevant academic research and scientific papers

Dynamic substrate enhancement for the identification of specific, second-site-binding fragments targeting a set of protein tyrosine phosphatases

Schmidt, Marco F.,Groves, Matthew R.,Rademann, Joerg

, p. 2640 - 2646 (2012/05/07)

Protein tyrosine phosphatases (PTPs) are key regulators in living systems and thus are attractive drug targets. The development of potent, selective PTP inhibitors has been a difficult challenge mainly due to the high homology of the phosphotyrosine substrate pockets. Here, a strategy of dynamic substrate enhancement is described targeting the secondary binding sites of PTPs. By screening four different PTPs from bacterial (MptpA) and human origin (PTP1B, HePtp, Shp2) with this assay, specific fragments were identified. One highly specific fragment that binds to the secondary site of Mycobacterium tuberculosis protein tyrosine phosphatase A (MptpA) was characterized in order to validate the assay concept. Finally by covalently linking the secondary fragment to a phosphotyrosine mimetic, a moderately active but highly specific inhibitor of MptpA was obtained.

Convenient synthesis of primary sulfonamides

Greenfield, Alexander,Grosanu, Cristina

body text, p. 6300 - 6303 (2009/04/06)

An efficient protocol for a one-pot synthesis of mono-sulfonamides has been developed. It features utilization of excess of sulfonylating agent followed by base mediated recovery of the primary sulfonamide.

Substituted peptide derivatives

-

, (2013/12/16)

The invention provides a series of novel substituted peptide derivatives of the formulae Ia, Ib and Ic (set out hereinafter) and pharmaceutically acceptable salts thereof, in which the radicals A, R1, R2 and R4-R9 have the meanings defined in the following specification. The compounds of formulae Ia, Ib, and Ic are inhbitors of human leukocytic elastase. The invention also provides pharmaceutical compositions containing a compound of formula Ia, Ib or Ic, or a pharmaceutically acceptable salt thereof and processes and intermediates for the manufacture of compounds of formulae Ia, Ib, and Ic.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 5433-54-5